| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 4.74e-05 | 85 | 47 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 6.95e-05 | 34 | 47 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 1.14e-04 | 40 | 47 | 3 | GO:0016896 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 1.62e-04 | 45 | 47 | 3 | GO:0004532 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.73e-04 | 145 | 47 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.19e-04 | 62 | 47 | 3 | GO:0016796 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 4.82e-04 | 65 | 47 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | sodium ion binding | 4.85e-04 | 14 | 47 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | metalloendopeptidase inhibitor activity | 6.37e-04 | 16 | 47 | 2 | GO:0008191 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.21e-04 | 17 | 47 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | flippase activity | 7.21e-04 | 17 | 47 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 9.04e-04 | 19 | 47 | 2 | GO:0005003 | |
| GeneOntologyMolecularFunction | exonuclease activity | 1.33e-03 | 92 | 47 | 3 | GO:0004527 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.70e-03 | 26 | 47 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.70e-03 | 26 | 47 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.97e-03 | 28 | 47 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 2.57e-03 | 32 | 47 | 2 | GO:0140142 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 3.43e-03 | 37 | 47 | 2 | GO:0000175 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 3.80e-03 | 39 | 47 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 4.03e-03 | 136 | 47 | 3 | GO:0004540 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 4.60e-03 | 43 | 47 | 2 | GO:0004177 | |
| GeneOntologyCellularComponent | T-tubule | 2.98e-05 | 79 | 47 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | neuronal cell body | 8.62e-05 | 835 | 47 | 9 | GO:0043025 | |
| GeneOntologyCellularComponent | axon | 1.41e-04 | 891 | 47 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | cell body | 1.93e-04 | 929 | 47 | 9 | GO:0044297 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 4.43e-04 | 14 | 47 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 6.59e-04 | 17 | 47 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | sarcolemma | 8.69e-04 | 190 | 47 | 4 | GO:0042383 | |
| GeneOntologyCellularComponent | node of Ranvier | 9.16e-04 | 20 | 47 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | anchoring junction | 1.36e-03 | 976 | 47 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | transporter complex | 1.39e-03 | 550 | 47 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.45e-03 | 1228 | 47 | 9 | GO:0036477 | |
| GeneOntologyCellularComponent | cation channel complex | 1.90e-03 | 235 | 47 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | axon initial segment | 1.93e-03 | 29 | 47 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.93e-03 | 29 | 47 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | cell-cell junction | 2.00e-03 | 591 | 47 | 6 | GO:0005911 | |
| GeneOntologyCellularComponent | focal adhesion | 2.74e-03 | 431 | 47 | 5 | GO:0005925 | |
| GeneOntologyCellularComponent | cell surface | 3.07e-03 | 1111 | 47 | 8 | GO:0009986 | |
| GeneOntologyCellularComponent | cell-substrate junction | 3.08e-03 | 443 | 47 | 5 | GO:0030055 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 3.48e-03 | 39 | 47 | 2 | GO:0031463 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 4.59e-03 | 934 | 47 | 7 | GO:0048471 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.81e-03 | 46 | 47 | 2 | GO:0005891 | |
| HumanPheno | Focal automatism seizure | 5.50e-06 | 12 | 16 | 3 | HP:0032898 | |
| Domain | Na_trans_cytopl | 8.85e-05 | 6 | 46 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 8.85e-05 | 6 | 46 | 2 | IPR024583 | |
| Domain | PROTEIN_KINASE_TYR | 9.44e-05 | 97 | 46 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 9.44e-05 | 97 | 46 | 4 | IPR008266 | |
| Domain | Na_channel_asu | 2.64e-04 | 10 | 46 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.64e-04 | 10 | 46 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 2.64e-04 | 10 | 46 | 2 | PF06512 | |
| Domain | Pkinase_Tyr | 2.83e-04 | 129 | 46 | 4 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.66e-04 | 138 | 46 | 4 | IPR001245 | |
| Domain | Gal_Oxase/kelch_b-propeller | 4.13e-04 | 59 | 46 | 3 | IPR011043 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 5.30e-04 | 14 | 46 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 5.30e-04 | 14 | 46 | 2 | PS00790 | |
| Domain | Eph_TM | 5.30e-04 | 14 | 46 | 2 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 5.30e-04 | 14 | 46 | 2 | IPR001426 | |
| Domain | EPH_lbd | 5.30e-04 | 14 | 46 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 5.30e-04 | 14 | 46 | 2 | PF01404 | |
| Domain | P_typ_ATPase_c | 5.30e-04 | 14 | 46 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 5.30e-04 | 14 | 46 | 2 | IPR032631 | |
| Domain | EphA2_TM | 5.30e-04 | 14 | 46 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 5.30e-04 | 14 | 46 | 2 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 5.30e-04 | 14 | 46 | 2 | IPR001090 | |
| Domain | EPH_LBD | 5.30e-04 | 14 | 46 | 2 | PS51550 | |
| Domain | P-type_ATPase_IV | 5.30e-04 | 14 | 46 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 5.30e-04 | 14 | 46 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 5.30e-04 | 14 | 46 | 2 | PF16209 | |
| Domain | Kelch_1 | 6.82e-04 | 70 | 46 | 3 | PF01344 | |
| Domain | Kelch_1 | 6.82e-04 | 70 | 46 | 3 | IPR006652 | |
| Domain | TyrKc | 1.33e-03 | 88 | 46 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.33e-03 | 88 | 46 | 3 | IPR020635 | |
| Domain | NTR | 1.45e-03 | 23 | 46 | 2 | PS50189 | |
| Domain | Netrin_domain | 1.45e-03 | 23 | 46 | 2 | IPR001134 | |
| Domain | Frizzled_dom | 1.58e-03 | 24 | 46 | 2 | IPR020067 | |
| Domain | FZ | 1.58e-03 | 24 | 46 | 2 | PS50038 | |
| Domain | Fz | 1.58e-03 | 24 | 46 | 2 | PF01392 | |
| Domain | Ephrin_rec_like | 1.72e-03 | 25 | 46 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.72e-03 | 25 | 46 | 2 | IPR011641 | |
| Domain | TIMP-like_OB-fold | 1.86e-03 | 26 | 46 | 2 | IPR008993 | |
| Domain | - | 2.00e-03 | 27 | 46 | 2 | 2.130.10.80 | |
| Domain | Kinase-like_dom | 2.03e-03 | 542 | 46 | 6 | IPR011009 | |
| Domain | Ion_trans_dom | 2.78e-03 | 114 | 46 | 3 | IPR005821 | |
| Domain | Ion_trans | 2.78e-03 | 114 | 46 | 3 | PF00520 | |
| Domain | - | 2.81e-03 | 32 | 46 | 2 | 3.40.1110.10 | |
| Domain | - | 2.81e-03 | 32 | 46 | 2 | 2.70.150.10 | |
| Domain | Gal_Oxidase_b-propeller | 3.17e-03 | 34 | 46 | 2 | IPR015916 | |
| Domain | ATPase_P-typ_cyto_domN | 3.35e-03 | 35 | 46 | 2 | IPR023299 | |
| Domain | P_typ_ATPase | 3.54e-03 | 36 | 46 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 3.54e-03 | 36 | 46 | 2 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 3.54e-03 | 36 | 46 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.74e-03 | 37 | 46 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.74e-03 | 37 | 46 | 2 | PF00122 | |
| Domain | EGF-like_CS | 3.84e-03 | 261 | 46 | 4 | IPR013032 | |
| Domain | EGF_2 | 4.05e-03 | 265 | 46 | 4 | PS01186 | |
| Domain | BTB-kelch_protein | 5.03e-03 | 43 | 46 | 2 | IPR017096 | |
| Domain | PROTEIN_KINASE_ATP | 5.25e-03 | 459 | 46 | 5 | PS00107 | |
| Domain | Growth_fac_rcpt_ | 6.67e-03 | 156 | 46 | 3 | IPR009030 | |
| Domain | Prot_kinase_dom | 6.83e-03 | 489 | 46 | 5 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 7.06e-03 | 493 | 46 | 5 | PS50011 | |
| Pathway | BIOCARTA_RECK_PATHWAY | 1.63e-06 | 9 | 39 | 3 | MM1579 | |
| Pathway | BIOCARTA_RECK_PATHWAY | 1.63e-06 | 9 | 39 | 3 | M22068 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 24335752 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 29649454 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 27056569 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22438955 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.79e-06 | 2 | 47 | 2 | 10827969 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19694741 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 9724659 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20579139 | ||
| Pubmed | Ascorbate-induced osteoblast differentiation recruits distinct MMP-inhibitors: RECK and TIMP-2. | 1.79e-06 | 2 | 47 | 2 | 18989628 | |
| Pubmed | TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis. | 1.79e-06 | 2 | 47 | 2 | 26331622 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.79e-06 | 2 | 47 | 2 | 1317301 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 9422789 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30794673 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 33096315 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 31439038 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24112707 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26311622 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24710006 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.79e-06 | 2 | 47 | 2 | 15249644 | |
| Pubmed | Proteolysis of EphA2 Converts It from a Tumor Suppressor to an Oncoprotein. | 1.79e-06 | 2 | 47 | 2 | 26130649 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 35446024 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17991754 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 25987077 | ||
| Pubmed | Involvement of MT1-MMP and TIMP-2 in human periodontal disease. | 1.79e-06 | 2 | 47 | 2 | 20233321 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21377452 | ||
| Pubmed | [Expression of MT1-MMP and RECK protein in human gastric carcinoma]. | 1.79e-06 | 2 | 47 | 2 | 22338226 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19551841 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17425593 | ||
| Pubmed | EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion. | 1.79e-06 | 2 | 47 | 2 | 23629968 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30693367 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 28784306 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 32185219 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 12610651 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 32005694 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 29265076 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 8743942 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 17329256 | ||
| Pubmed | Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma. | 5.36e-06 | 3 | 47 | 2 | 19709349 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 23859570 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 9648071 | ||
| Pubmed | Activation ratio of MMP-2 and expression of MT1-MMP are correlated in thymic epithelial tumours. | 5.36e-06 | 3 | 47 | 2 | 17886098 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 18784617 | ||
| Pubmed | [The role of matrix metalloproteinases and their tissue inhibitors in oral lichen planus]. | 5.36e-06 | 3 | 47 | 2 | 17067460 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 17544618 | ||
| Pubmed | The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. | 5.36e-06 | 3 | 47 | 2 | 16776850 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 32730638 | ||
| Pubmed | MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. | 5.36e-06 | 3 | 47 | 2 | 19197139 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16737551 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 32845893 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 8152808 | ||
| Pubmed | NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis. | 5.36e-06 | 3 | 47 | 2 | 24202705 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 12372458 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 28518218 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 19270815 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25405519 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 18329693 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 20056917 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25155934 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 17928448 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 14973256 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25552509 | ||
| Pubmed | GDE2-RECK controls ADAM10 α-secretase-mediated cleavage of amyloid precursor protein. | 5.36e-06 | 3 | 47 | 2 | 33731436 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 17537961 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 35031483 | ||
| Pubmed | Enhanced plasticity of retinothalamic projections in an ephrin-A2/A5 double mutant. | 1.07e-05 | 4 | 47 | 2 | 11567058 | |
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 1.07e-05 | 4 | 47 | 2 | 26637798 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 29578003 | ||
| Pubmed | EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma. | 1.07e-05 | 4 | 47 | 2 | 16425263 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 21156207 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 35801810 | ||
| Pubmed | RECK and TIMP-2 mediate inhibition of MMP-2 and MMP-9 by Annona muricata. | 1.07e-05 | 4 | 47 | 2 | 32661216 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 26666565 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.07e-05 | 4 | 47 | 2 | 8974318 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 1679748 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 8812438 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 19398467 | ||
| Pubmed | Addition of poly(A) and poly(A)-rich tails during RNA degradation in the cytoplasm of human cells. | 1.78e-05 | 5 | 47 | 2 | 20368444 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 24095877 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 19949912 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 15247230 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 8804434 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 19339693 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 24337656 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 23756462 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 22200690 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 7973638 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 2.67e-05 | 6 | 47 | 2 | 23652591 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 19020757 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 12950084 | ||
| Pubmed | 2.82e-05 | 263 | 47 | 5 | 34702444 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 9325265 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 19542530 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.74e-05 | 7 | 47 | 2 | 25818041 | |
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 11747814 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 30822518 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 4.39e-05 | 974 | 47 | 8 | 28675297 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 11865039 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 35101451 | ||
| Pubmed | 5.02e-05 | 1293 | 47 | 9 | 15342556 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 11675412 | ||
| Cytoband | 2q24.3 | 1.22e-04 | 16 | 47 | 2 | 2q24.3 | |
| Cytoband | 19q13.1 | 1.47e-03 | 55 | 47 | 2 | 19q13.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.08e-04 | 9 | 32 | 2 | 1203 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.73e-04 | 14 | 32 | 2 | 1095 | |
| GeneFamily | ATPase phospholipid transporting | 3.14e-04 | 15 | 32 | 2 | 1210 | |
| GeneFamily | Kelch like|BTB domain containing | 2.50e-03 | 42 | 32 | 2 | 617 | |
| GeneFamily | Fibronectin type III domain containing | 2.79e-03 | 160 | 32 | 3 | 555 | |
| GeneFamily | Sterile alpha motif domain containing | 1.06e-02 | 88 | 32 | 2 | 760 | |
| GeneFamily | WD repeat domain containing | 1.09e-02 | 262 | 32 | 3 | 362 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 2.34e-02 | 134 | 32 | 2 | 861 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B | 5.77e-06 | 554 | 47 | 8 | M2244 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 1.38e-05 | 294 | 47 | 6 | M1804 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.18e-06 | 200 | 47 | 5 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.18e-06 | 200 | 47 | 5 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.18e-06 | 200 | 47 | 5 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.38e-05 | 159 | 47 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 164 | 47 | 4 | 8f074940afdbda88a4b697a7ddc687e09a4b818b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 164 | 47 | 4 | a784f47f67a5eda84d58ad7d9400e3978edbb487 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 164 | 47 | 4 | 1a1795969673232191425dde84ab24ee6a98143f | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.16e-05 | 171 | 47 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.30e-05 | 185 | 47 | 4 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 185 | 47 | 4 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.07e-05 | 193 | 47 | 4 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.07e-05 | 193 | 47 | 4 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-05 | 195 | 47 | 4 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-05 | 197 | 47 | 4 | 5593721407f61fc5bc3f2f8bf8fa2604c4e29565 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-05 | 197 | 47 | 4 | a1ae1aa797762a3768e14434c7e5cd19c595ecb3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-05 | 198 | 47 | 4 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue|World / Sample_Type by Project: Shred V9 | 3.81e-04 | 134 | 47 | 3 | 9940a710a5d6670244cce5e19f88b4195a59875b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.89e-04 | 135 | 47 | 3 | c7c30b993b3ddac8f1677d5fe47dc2e66d0d26ac | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.06e-04 | 137 | 47 | 3 | a69976938d4e89315ec0be3a332b91ddf3799d65 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 4.24e-04 | 139 | 47 | 3 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 4.89e-04 | 146 | 47 | 3 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.09e-04 | 148 | 47 | 3 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.19e-04 | 149 | 47 | 3 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.29e-04 | 150 | 47 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.29e-04 | 150 | 47 | 3 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.60e-04 | 153 | 47 | 3 | 764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-04 | 158 | 47 | 3 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-04 | 158 | 47 | 3 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.27e-04 | 159 | 47 | 3 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-04 | 159 | 47 | 3 | d9e535cf9a0a2302268f2897b010dcecc6426e41 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-04 | 159 | 47 | 3 | 29999c87f5823f734e5cbf8ea8b729ec017db9b3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-04 | 159 | 47 | 3 | 4b840da854390f8285c219314cff4434d7ffcacc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.27e-04 | 159 | 47 | 3 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.38e-04 | 160 | 47 | 3 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.50e-04 | 161 | 47 | 3 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.61e-04 | 162 | 47 | 3 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-04 | 162 | 47 | 3 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 6.73e-04 | 163 | 47 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-04 | 164 | 47 | 3 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-04 | 164 | 47 | 3 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.98e-04 | 165 | 47 | 3 | 15fd9d21dccfa80656a6fa3b72286a6a9252d403 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-04 | 165 | 47 | 3 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-04 | 166 | 47 | 3 | 019d365df44c3bbd88c1f4bdceb3de0ff76d3e8d | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-04 | 167 | 47 | 3 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.35e-04 | 168 | 47 | 3 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-04 | 169 | 47 | 3 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | Ionocyte-iono-1|World / Class top | 7.48e-04 | 169 | 47 | 3 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.48e-04 | 169 | 47 | 3 | f47c4fbdc2a38745ec1b35104b85121c1413875a | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-04 | 170 | 47 | 3 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-04 | 170 | 47 | 3 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-04 | 170 | 47 | 3 | 0b5ddc7d452db0a389927a367914f7d257703f7e | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.74e-04 | 171 | 47 | 3 | 943fbca8a6ac04052a2a85aca7b21a3461cd96f7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-04 | 171 | 47 | 3 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 7.87e-04 | 172 | 47 | 3 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-04 | 173 | 47 | 3 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 8.00e-04 | 173 | 47 | 3 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | 10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 8.13e-04 | 174 | 47 | 3 | a5838821bba2be790d32331ff529d466e9974268 | |
| ToppCell | droplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 174 | 47 | 3 | cf4e0567f2a4ebe5534046b1c091af59b55bdc4f | |
| ToppCell | 10x5'-blood-Mast|blood / Manually curated celltypes from each tissue | 8.13e-04 | 174 | 47 | 3 | 3a8a253213b207e3ff56f94a74996b8d9ad47aa1 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.13e-04 | 174 | 47 | 3 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-04 | 175 | 47 | 3 | 43be63976da5ad0764d24d90919a77ce46068f52 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.27e-04 | 175 | 47 | 3 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.27e-04 | 175 | 47 | 3 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.55e-04 | 177 | 47 | 3 | 6da88c358b3a2e47fa3472217a38b6b00ad7b280 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 8.69e-04 | 178 | 47 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | PSB-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.69e-04 | 178 | 47 | 3 | 45bdbb96094c97756e1b6eebd80eadd8472143f2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 179 | 47 | 3 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 8.83e-04 | 179 | 47 | 3 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 179 | 47 | 3 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 179 | 47 | 3 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.83e-04 | 179 | 47 | 3 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-04 | 179 | 47 | 3 | 0b6731d9554f8bed1899c165a50e6b329ea19a6d | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.83e-04 | 179 | 47 | 3 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-04 | 179 | 47 | 3 | b70509288aaf4457afd350f6c45784521337ce0d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 8.97e-04 | 180 | 47 | 3 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-04 | 181 | 47 | 3 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 9.12e-04 | 181 | 47 | 3 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-04 | 181 | 47 | 3 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.26e-04 | 182 | 47 | 3 | 86a2330ada7637144a67afbf9f3a902901ab1130 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 9.26e-04 | 182 | 47 | 3 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.26e-04 | 182 | 47 | 3 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.26e-04 | 182 | 47 | 3 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.26e-04 | 182 | 47 | 3 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.26e-04 | 182 | 47 | 3 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.41e-04 | 183 | 47 | 3 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 9.41e-04 | 183 | 47 | 3 | 0bcbd60e10b9d6898915dab1987fd46dc7238b19 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 183 | 47 | 3 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-04 | 184 | 47 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-04 | 184 | 47 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-04 | 184 | 47 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-04 | 184 | 47 | 3 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.56e-04 | 184 | 47 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-04 | 184 | 47 | 3 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| Drug | 8(S),15(S)-diHETE | 3.69e-06 | 15 | 47 | 3 | CID000001897 | |
| Drug | bis(4-hydroxycinnamoyl)methane | 3.22e-05 | 30 | 47 | 3 | ctd:C034786 | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 4.89e-05 | 194 | 47 | 5 | 2430_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; PC3; HT_HG-U133A | 4.89e-05 | 194 | 47 | 5 | 4589_DN | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HG-U133A | 5.01e-05 | 195 | 47 | 5 | 1946_UP | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; HL60; HT_HG-U133A | 5.01e-05 | 195 | 47 | 5 | 2382_UP | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.14e-05 | 196 | 47 | 5 | 5446_DN | |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 1545_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 1470_DN | |
| Drug | Piroxicam [36322-90-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.39e-05 | 198 | 47 | 5 | 7445_DN | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.52e-05 | 199 | 47 | 5 | 7212_DN | |
| Drug | demethoxycurcumin | 6.61e-05 | 38 | 47 | 3 | ctd:C050229 | |
| Disease | Marfan syndrome (is_marker_for) | 1.49e-05 | 4 | 47 | 2 | DOID:14323 (is_marker_for) | |
| Disease | Dupuytren Contracture | 2.68e-05 | 108 | 47 | 4 | EFO_0004229 | |
| Disease | Seizure, Febrile, Simple | 5.19e-05 | 7 | 47 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 5.19e-05 | 7 | 47 | 2 | C0751057 | |
| Disease | frozen shoulder | 5.19e-05 | 7 | 47 | 2 | EFO_1000941 | |
| Disease | Febrile Convulsions | 8.88e-05 | 9 | 47 | 2 | C0009952 | |
| Disease | glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement | 8.88e-05 | 9 | 47 | 2 | EFO_0800275 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 8.88e-05 | 9 | 47 | 2 | C3502809 | |
| Disease | hip bone mineral density, hip bone size | 9.89e-05 | 56 | 47 | 3 | EFO_0004844, EFO_0007702 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.11e-04 | 10 | 47 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.11e-04 | 10 | 47 | 2 | EFO_0008200 | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.11e-04 | 10 | 47 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.62e-04 | 12 | 47 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Ischemic stroke | 1.63e-04 | 324 | 47 | 5 | HP_0002140 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.92e-04 | 13 | 47 | 2 | C0751122 | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 2.23e-04 | 14 | 47 | 2 | DOID:14004 (is_marker_for) | |
| Disease | MMR-related febrile seizures | 2.57e-04 | 15 | 47 | 2 | EFO_0006519 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.94e-04 | 16 | 47 | 2 | C0393706 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.74e-04 | 18 | 47 | 2 | HP_0002373 | |
| Disease | anxiety disorder (implicated_via_orthology) | 5.62e-04 | 22 | 47 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | eyelid sagging measurement | 1.19e-03 | 32 | 47 | 2 | EFO_0009360 | |
| Disease | Cholestasis, Extrahepatic | 1.19e-03 | 32 | 47 | 2 | C0005398 | |
| Disease | Squamous cell carcinoma of lung | 1.19e-03 | 32 | 47 | 2 | C0149782 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDDPDYWRTVQDPMT | 176 | Q14137 | |
| AEEVCSMSWYTPMPI | 161 | Q6ZRH7 | |
| MDCPAALYQLMLDCW | 901 | P54756 | |
| CYFMHCPQMEWENPN | 471 | A6QL63 | |
| QMMRECWYPNPSARL | 466 | P37023 | |
| DWCSLNNPPLEMMFD | 386 | Q9NZ32 | |
| WCIGLYNVMFTAMPP | 891 | Q9Y2Q0 | |
| MCVTCNPPSNPYWIM | 1276 | Q9P241 | |
| SDPSAIMAPFYQWMD | 251 | P50281 | |
| PDYCPETMVEIWNCM | 71 | O95980 | |
| MYGMCESLWEPNMDP | 146 | P49720 | |
| RAEPPSSYKVMCQWM | 231 | Q9NU53 | |
| GQCMEWYTMSTCPPE | 971 | O75882 | |
| TCMDWSLQYPELMVA | 291 | O14576 | |
| CVMANPTYDIDPNWD | 1181 | Q9H792 | |
| EIDYWPLLDMMPANS | 231 | Q7L985 | |
| MPPDEYCLMWVTADL | 491 | Q8WTR4 | |
| LAPQYPWQSNDMSMN | 216 | Q9NPJ6 | |
| EKPAFDYPMNQMSVW | 1241 | P78509 | |
| NEMDTAQFCMQYWPE | 1276 | O14522 | |
| QKCSTPVYPWMQRMN | 121 | P17509 | |
| PVYPWMQRMNSCNSS | 126 | P17509 | |
| FLLPECPMMHISNNW | 491 | Q9UII4 | |
| QMPEALQASDLWYCP | 86 | Q9UIM3 | |
| SWEALQPMTYPMDNC | 401 | Q9UJP4 | |
| MVMQCYDPDTDLWSL | 436 | Q9UJP4 | |
| FWASMMEAASCPPDY | 591 | Q86TI2 | |
| AQMCEMPVNTPESPW | 441 | Q8TF46 | |
| DCPSAIYQLMMQCWQ | 841 | P29317 | |
| WNVNAPPTFHSEMMY | 386 | P43251 | |
| YNPMTNQWSPCAPMS | 396 | Q14145 | |
| KNPMNFFPEQMVTWC | 256 | Q13322 | |
| DASFMQTLWNMNPIC | 191 | P21817 | |
| DQWSPAFMVPDSCMV | 141 | Q8TEY5 | |
| SLYENPWTIPNMLSM | 101 | Q9UJA2 | |
| FDSCAWMPNLPPSMQ | 561 | O15296 | |
| SAAPMDWMQEYRCLL | 286 | Q7L2K0 | |
| QCSIRMMDADPKWPY | 1851 | A0AVI2 | |
| DPQTSYMVSAWARMC | 606 | O60518 | |
| NCVFMTMSNPPDWTK | 141 | P35498 | |
| MWAAIPMQSEPQYAD | 146 | Q9UNK9 | |
| DCPPRMYSLMTECWN | 716 | Q01973 | |
| MYSLMTECWNEIPSR | 721 | Q01973 | |
| TAWNAATMAPPVMAY | 586 | Q13492 | |
| TECPPMMDTEYTKLW | 851 | P55060 | |
| DDCEPLMKMYNHSWP | 106 | Q6FHJ7 | |
| TNCVFMTMSNPPDWT | 141 | Q99250 | |
| MTMSNPPDWTKNVEY | 146 | Q99250 | |
| MIPCYISSPDECLWM | 161 | P16035 | |
| NVQSMDNMCWPAPSQ | 1421 | Q8IZH2 | |
| MAQSLDPSYLMCWIG | 886 | Q6PGP7 | |
| MQEEMESNPDSPYWH | 166 | Q8NHP8 | |
| WEPHEYPASMERMQN | 471 | Q562E7 | |
| YPASMERMQNWTPDE | 476 | Q562E7 |